{
  "pageTables": [
    {
      "page": 1,
      "tables": [
        [ "", "" ],
        [ "ABIM Laboratory Test Reference Ranges  ̶  January 2025", "" ],
        [ "Laboratory Tests", "Reference Ranges" ],
        [ "1,25-Dihydroxyvitamin D\n      (1,25-dihydroxycholecalciferol), serum", "See Vitamin D metabolites" ],
        [ "1,5-Anhydroglucitol, serum or plasma", "Female: 6.8–29.3 μg/mL; male: 10.7–32 μg/mL" ],
        [ "17-Hydroxycorticosteroids (Porter-Silber), urine", "Female: 2–8 mg/24 hr; male: 3–10 mg/24 hr" ],
        [ "17-Hydroxyprogesterone, serum", "" ],
        [ "     Female, follicular", "˂80 ng/dL " ],
        [ "     Female, luteal", "˂285 ng/dL " ],
        [ "     Female, postmenopausal", "˂51 ng/dL " ],
        [ "     Male (adult)", "˂220 ng/dL " ],
        [ "25-Hydroxyvitamin D\n(25-hydroxycholecalciferol), serum", "See Vitamin D metabolites" ],
        [ "5-Hydroxyindoleacetic acid, urine", "2–9 mg/24 hr" ],
        [ "5'-Nucleotidase, serum", "0.3–2.6 (Bodansky) units/dL (0–15 U/L)" ],
        [ "6-Thioguanine, whole blood", "230–400 pmol/8x108 RBCs" ],
        [ "Absolute basophil count", "0–110/μL" ],
        [ "Absolute eosinophil count", "0–330/μL" ],
        [ "Absolute lymphocyte count", "1200–4950/μL" ],
        [ "Absolute monocyte count", "0–660/μL" ],
        [ "Absolute neutrophil count (ANC)", "2000–8250/μL" ],
        [ "Acid phosphatase, serum", "" ],
        [ "     Total", "0.5–2.0 (Bodansky) units/mL" ],
        [ "     Prostatic fraction", "0.1–0.4 unit/mL" ],
        [ "ACTH, plasma", "10–60 pg/mL " ],
        [ "Activated partial thromboplastin time", "25–35 seconds" ],
        [ "ADAMTS13 activity", ">60%" ],
        [ "Adrenocorticotropic hormone (ACTH), plasma ", "10–60 pg/mL " ],
        [ "Albumin, serum", "3.5–5.5 g/dL" ],
        [ "Albumin, urine", "˂25 mg/24 hr" ],
        [ "Albumin-to-creatinine ratio, urine", "˂30 mg/g" ],
        [ "Aldolase, serum", "0.8–3.0 IU/mL" ],
        [ "Aldosterone, plasma", "" ],
        [ "     Supine or seated", "≤10 ng/dL" ],
        [ "     Standing", "˂21 ng/dL" ],
        [ " Low-sodium diet (supine)", "≤30 ng/dL" ],
        [ "Aldosterone, urine", "5–19 μg/24 hr" ],
        [ "Alkaline phosphatase, serum", "30–120 U/L" ],
        [ "Alpha1-antitrypsin (AAT), serum", "150–350 mg/dL" ],
        [ "Alpha2-antiplasmin activity, plasma", "75%–115%" ],
        [ "Alpha-amino nitrogen, urine", "100–290 mg/24 hr" ],
        [ "Alpha-fetoprotein, serum", "˂10 ng/mL" ],
        [ "Amino acids, urine", "200–400 mg/24 hr" ],
        [ "Aminotransferase, serum alanine (ALT, SGPT)", "10–40 U/L" ],
        [ "Aminotransferase, serum aspartate (AST, SGOT)", "10–40 U/L" ],
        [ "Ammonia, plasma", "40–70 μg/dL" ],
        [ "Amylase, serum", "25–125 U/L (80–180 [Somogyi] units/dL)" ],
        [ "Amylase, urine", "1–17 U/hr" ]
      ],
      "merges": {
        "0-0": {
          "row": 0,
          "col": 0,
          "width": 2,
          "height": 1
        },
        "1-0": {
          "row": 1,
          "col": 0,
          "width": 2,
          "height": 1
        }
      },
      "merge_alias": {
        "0-1": "0-0",
        "1-1": "1-0"
      },
      "width": 2,
      "height": 47
    },
    {
      "page": 2,
      "tables": [
        [ "Androstenedione, serum", "Female: 30–200 ng/dL; male: 40–150 ng/dL" ],
        [ "Angiotensin-converting enzyme, serum", "8–53 U/L" ],
        [ "Anion gap, serum", "7–13 mEq/L" ],
        [ "Antibodies to double-stranded DNA", "0–7 IU/mL" ],
        [ "Anticardiolipin antibodies", "" ],
        [ "     IgG", "˂20 GPL" ],
        [ "     IgM", "˂20 MPL" ],
        [ "Anti-cyclic citrullinated peptide antibodies ", "˂20 units" ],
        [ "Antideoxyribonuclease B ", "˂280 units" ],
        [ "Anti-F-actin antibodies, serum", "≤1:80" ],
        [ "Antihistone antibodies", "˂1:16" ],
        [ "Anti-liver-kidney microsomal antibodies (anti-LKM)", "˂1:20" ],
        [ "Antimitochondrial antibodies", "≤1:5" ],
        [ "Anti–myelin associated glycoprotein antibody", "˂1:1600" ],
        [ "Antimyeloperoxidase antibodies", "˂1.0 U" ],
        [ "Antinuclear antibodies", "≤1:40" ],
        [ "Anti-phospholipase A2 receptor (PLA2R) antibodies, \nserum\n[ELISA]", "Negative: <14 RU/mL\nBorderline: 14 – <20 RU/mL\nPositive: ≥20 RU/mL" ],
        [ "Anti-RNP antibodies\n[by chemiluminescence method]", "<20 CU" ],
        [ "Anti-RNP antibodies\n[by multiplex flow immunoassay]", "<1.0 AI" ],
        [ "Anti-Scl-70 antibodies (topoisomerase 1 antibodies), IgG, \nserum", "Negative: <1.0 U\n[Positive: ≥1.0 U]" ],
        [ "Anti–smooth muscle antibodies", "≤1:80" ],
        [ "Anti-SSA/Ro & anti-SSB antibodies\n[by chemiluminescence method]", "<20 CU" ],
        [ "Anti-SSA/Ro & anti-SSB antibodies\n[by multiplex flow immunoassay]", "<1.0 AI" ],
        [ "Antistreptolysin O titer", "˂200 Todd units" ],
        [ "Antithrombin activity", "80%–120%" ],
        [ "Antithyroglobulin antibodies", "˂20 U/mL" ],
        [ "Antithyroid peroxidase antibodies", "˂2.0 U/mL" ],
        [ "Anti-tissue transglutaminase antibodies", "See Tissue transglutaminase antibody" ],
        [ "Apolipoprotein A-1, serum", "Female: ≥140 mg/dL\nMale: ≥120 mg/dL" ],
        [ "Apolipoprotein B, serum", "Desirable: ˂90 mg/dL \nBorderline high: 90–119 mg/dL\nHigh: 120–139 mg/dL\nVery High: ≥140 mg/dL" ],
        [ "Arterial blood gas studies (patient\nbreathing room air):", "" ],
        [ "     pH", "7.38–7.44" ],
        [ "     PaCO2", "3842 mm Hg" ],
        [ "     PaO2", "75–100 mm Hg" ],
        [ "     Bicarbonate", "23–26 mEq/L" ],
        [ "     Oxygen saturation", "≥95%" ],
        [ "     Methemoglobin", "0.5%–3.0%" ],
        [ "Ascorbic acid (vitamin C), blood", "0.4–1.5 mg/dL" ],
        [ "Ascorbic acid, leukocyte", "16.5 ± 5.1 mg/dL of leukocytes" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 39
    },
    {
      "page": 3,
      "tables": [
        [ "(1,3)-Beta-D-glucan, serum            ", "˂60 pg/mL" ],
        [ "Beta-human chorionic gonadotropin (beta-hCG), serum", "Female, premenopausal nonpregnant: ˂1.0 U/L;\nfemale, postmenopausal: ˂7.0 U/L; male: ˂1.4 U/L" ],
        [ "Beta-human chorionic gonadotropin (beta-hCG), urine", "˂2 mIU/24 hr" ],
        [ "Beta2-glycoprotein I antibodies:", "" ],
        [ "     IgG", "˂21 SGU" ],
        [ "     IgM", "˂21 SMU" ],
        [ "Beta-hydroxybutyrate, serum", "˂0.4 mmol/L" ],
        [ "Beta2-microglobulin, serum", "0.54–2.75 mg/L" ],
        [ "Bicarbonate, serum", "23–28 mEq/L" ],
        [ "Bilirubin, serum ", "" ],
        [ "     Total", "0.3–1.0 mg/dL" ],
        [ "     Direct", "0.1–0.3 mg/dL" ],
        [ "     Indirect", "0.2–0.7 mg/dL" ],
        [ "Bleeding time (template)", "˂8 minutes" ],
        [ "Blood urea nitrogen (BUN), serum or plasma", "8–20 mg/dL" ],
        [ "Bone-specific alkaline phosphatase, serum", "Female, premenopausal: 4.5–16.9 μg/L\nFemale, postmenopausal: 7.0–22.4 μg/L\nMale, 25 years of age or older: 6.5–20.1 μg/L" ],
        [ "B-type natriuretic peptide, plasma", "˂100 pg/mL" ],
        [ "C peptide, serum", "0.8–3.1 ng/mL" ],
        [ "Calcitonin, serum", "Female: ≤5 pg/mL; male: ≤10 pg/mL" ],
        [ "Calcium, ionized, serum", "1.12–1.23 mmol/L" ],
        [ "Calcium, serum", "8.6–10.2 mg/dL" ],
        [ "Calcium, urine", "Female: ˂250 mg/24 hr; male: ˂300 mg/24 hr" ],
        [ "Carbohydrate antigens, serum", "" ],
        [ "      CA 19-9", "0–37 U/mL" ],
        [ "      CA 27-29", "˂38.0 U/mL" ],
        [ "      CA 125", "˂35 U/mL" ],
        [ "Carbon dioxide, serum", "23–30 mEq/L" ],
        [ "Carboxyhemoglobin, blood", "˂5%" ],
        [ "Carcinoembryonic antigen, plasma", "˂2.5 ng/mL" ],
        [ "Carotene, serum", "75–300 μg/dL" ],
        [ "Catecholamines, plasma", "" ],
        [ "      Dopamine", "˂30 pg/mL" ],
        [ "      Epinephrine", "" ],
        [ "           Supine", "˂50 pg/mL" ],
        [ "           Standing", "˂95 pg/mL" ],
        [ "      Norepinephrine", "" ],
        [ "           Supine", "112–658 pg/mL" ],
        [ "           Standing", "217–1109 pg/mL" ],
        [ "Catecholamines, urine", "" ],
        [ "       Dopamine", "65–400 μg/24 hr" ],
        [ "      Epinephrine", "2–24 μg/24 hr" ],
        [ "      Norepinephrine", "15–100 μg/24 hr" ],
        [ "      Total", "26–121 μg/24 hr" ],
        [ "CD4 T-lymphocyte count", "530–1570/μL" ],
        [ "Cell count, CSF:", "" ],
        [ " Leukocytes (WBCs)", "0–5 cells/μL" ],
        [ " Erythrocytes (RBCs)", "0/μL" ],
        [ "Ceruloplasmin, serum (plasma)", "25–43 mg/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 48
    },
    {
      "page": 4,
      "tables": [
        [ "Chloride, CSF", "120–130 mEq/L" ],
        [ "Chloride, serum", "98–106 mEq/L " ],
        [ "Chloride, urine", "" ],
        [ "      Random (\"spot\")", "mEq/L; varies" ],
        [ "24-hour measurement", "mEq/24 hr; varies with intake" ],
        [ "Cholesterol, serum", "" ],
        [ "      Total", "" ],
        [ "          Desirable", "˂200 mg/dL" ],
        [ "          Borderline-high", "200–239 mg/dL " ],
        [ "          High", ">239 mg/dL" ],
        [ " High-density lipoprotein", "" ],
        [ "          Low", "Female: ˂50 mg/dL; male: ˂40 mg/dL" ],
        [ " Low-density lipoprotein", "" ],
        [ "          Optimal", "˂100 mg/dL" ],
        [ "          Near-optimal", "100–129 mg/dL" ],
        [ "          Borderline-high", "130–159 mg/dL" ],
        [ "          High", "160–189 mg/dL" ],
        [ "          Very high", ">189 mg/dL" ],
        [ "Cholinesterase, serum (pseudocholinesterase)", "≥0.5 pH unit/hr" ],
        [ "     Packed cells", "≥0.7 pH unit/hr" ],
        [ "Chorionic gonadotropin, beta-human\n     (beta-hCG), serum", "See Beta-human chorionic gonadotropin (beta-hCG), \nserum" ],
        [ "Chorionic gonadotropin, beta-human\n     (beta-hCG), urine", "See Beta-human chorionic gonadotropin (beta-hCG), \nurine" ],
        [ "Chromogranin A, serum", "˂93 ng/mL" ],
        [ "Citrate, urine", "250–1000 mg/24 hr" ],
        [ "Coagulation factors, plasma ", "" ],
        [ "     Factor I (fibrinogen)", "200–400 mg/dL" ],
        [ "     Factor II (prothrombin)", "60%–130%" ],
        [ "     Factor V (accelerator globulin)", "60%–130%" ],
        [ "     Factor VII (proconvertin)", "60%–130%" ],
        [ "     Factor VIII (antihemophilic globulin)", "50%–150%" ],
        [ "     Factor IX (plasma thromboplastin component)", "60%–130%" ],
        [ "     Factor X (Stuart factor)", "60%–130%" ],
        [ "     Factor XI (plasma thromboplastin antecedent)", "60%–130%" ],
        [ "     Factor XII (Hageman factor)", "60%–130%" ],
        [ " Factor XIII", "57%–192%" ],
        [ "Cold agglutinin titer", ">1:64 positive" ],
        [ "Complement components, serum", "" ],
        [ "     C3", "100–233 mg/dL" ],
        [ "     C4", "14–48 mg/dL" ],
        [ "     CH50", "110–190 units/mL" ],
        [ "Copper, serum", "100–200 μg/dL" ],
        [ "Copper, urine", "0–100 μg/24 hr" ],
        [ "Coproporphyrin, urine", "50–250 μg/24 hr" ],
        [ "Cortisol, free, urine", "4–50 μg/24 hr" ],
        [ "Cortisol, plasma", "" ],
        [ "     8 AM", "5–25 μg/dL" ],
        [ "     4 PM", "˂10 μg/dL" ],
        [ "     1 hour after  cosyntropin ", "≥18 μg/dL" ],
        [ " Overnight suppression test (1-mg)", "˂1.8 μg/dL" ],
        [ " Overnight suppression test (8-mg)", ">50% reduction in cortisol" ],
        [ "Cortisol, saliva, 11 PM – midnight", "˂0.09 μg/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 51
    },
    {
      "page": 5,
      "tables": [
        [ "C-reactive protein, serum", "≤0.8 mg/dL" ],
        [ "C-reactive protein (high sensitivity), serum", "Low cardiovascular risk: ˂1.0 mg/L;\nAverage cardiovascular risk: 1.0–3.0 mg/L;\nHigh cardiovascular risk: >3.0 mg/L" ],
        [ "Creatine kinase, serum", "" ],
        [ "     Total", "Female: 30–135 U/L; male: 55–170 U/L" ],
        [ "     MB isoenzymes", "˂5% of total" ],
        [ "Creatine, urine", "Female: 0–100 mg/24 hr; male: 0–40 mg/24 hr" ],
        [ "Creatinine clearance, urine", "90–140 mL/min/1.73 m2" ],
        [ "Creatinine, serum", "Female: 0.50–1.10 mg/dL; male: 0.70–1.30 mg/dL" ],
        [ "Creatinine, urine", "" ],
        [ "     Random (\"spot\")", "mg/dL; varies" ],
        [ "24-hour measurement", "15–25 mg/kg body weight/24 hr" ],
        [ "D-dimer, plasma", "˂0.5 μg/mL" ],
        [ "Dehydroepiandrosterone sulfate (DHEA-S), serum", "Female: 44–332 μg/dL; male: 89–457 μg/dL" ],
        [ "Delta-aminolevulinic acid, serum", "˂20 μg/dL" ],
        [ "Dihydrotestosterone, serum", "Adult male: 25–80 ng/dL" ],
        [ "Dopamine, plasma", "˂30 pg/mL" ],
        [ "Dopamine, urine", "65–400 μg/24 hr" ],
        [ "D-Xylose absorption\n(after ingestion of 25 g of D-xylose)", "" ],
        [ "     Serum", "25–40 mg/dL" ],
        [ "     Urinary excretion", "4.5–7.5 g during a 5-hr period" ],
        [ "Electrolytes, serum", "" ],
        [ "     Sodium", "136–145 mEq/L" ],
        [ "     Potassium", "3.5–5.0 mEq/L" ],
        [ "     Chloride", "98–106 mEq/L" ],
        [ "     Bicarbonate", "23–28 mEq/L" ],
        [ "Epinephrine, plasma", "" ],
        [ "     Supine", "˂110 pg/mL" ],
        [ "     Standing", "˂140 pg/mL" ],
        [ "Epinephrine, urine", "˂20 μg/24 hr" ],
        [ "Erythrocyte count", "4.2–5.9 million/μL" ],
        [ "Erythrocyte sedimentation rate (Westergren)", "Female: 0–20 mm/hr; male: 0–15 mm/hr" ],
        [ "Erythrocyte survival rate (51Cr)", "T½ = 28 days" ],
        [ "Erythropoietin, serum", "4–26 mU/mL" ],
        [ "Estradiol, serum", "" ],
        [ "     Female, follicular", "10–180 pg/mL" ],
        [ "          Mid-cycle peak", "100–300 pg/mL" ],
        [ "          Luteal", "40–200 pg/mL" ],
        [ "          Postmenopausal", "˂10 pg/mL" ],
        [ "     Male", "20–50 pg/mL" ],
        [ "Estriol, urine", ">12 mg/24 hr" ],
        [ "Estrogen receptor protein", "Negative: ˂10 fmol/mg protein" ],
        [ "Estrone, serum", "10–60 pg/mL" ],
        [ "Ethanol, blood", "˂0.005% (˂5 mg/dL)" ],
        [ "     Coma level", ">0.5% (>500 mg/dL)" ],
        [ "     Intoxication", "≥0.08%–0.1% (≥80–100 mg/dL)" ],
        [ "Euglobulin clot lysis time", "2–4 hours at 37.0 C" ],
        [ "Factor XIII, B subunit, plasma", "60–130 U/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 47
    },
    {
      "page": 6,
      "tables": [
        [ "Fecal fat", "˂7 g/24 hr" ],
        [ "Fecal pH", "7.0–7.5" ],
        [ "Fecal weight", "˂250 g/24 hr" ],
        [ "Ferritin, serum", "Female: 24–307 ng/mL; male: 24–336 ng/mL" ],
        [ "Fibrin(ogen) degradation products", "˂10 μg/mL" ],
        [ "Fibrinogen, plasma", "200–400 mg/dL" ],
        [ "Fibroblast growth factor-23, serum", "30–80 RU/mL" ],
        [ "Folate, red cell", "150–450 ng/mL of packed cells " ],
        [ "Folate, serum", "1.8–9.0 ng/mL" ],
        [ "Follicle-stimulating hormone, serum", "" ],
        [ " Female, follicular/luteal", "2–9 mIU/mL (2–9 U/L)" ],
        [ "     Female, mid-cycle peak", "4–22 mIU/mL (4–22 U/L)" ],
        [ "     Female, postmenopausal", ">30 mIU/mL (>30 U/L)" ],
        [ "     Male (adult)", "1–7 mIU/mL (1–7 U/L)" ],
        [ "     Children, Tanner stages 1, 2", "0.5–8.0 mIU/mL (0.5–8.0 U/L)" ],
        [ "     Children, Tanner stages 3, 4, 5", "1–12 mIU/mL (1–12 U/L)" ],
        [ "Free kappa light chain, serum", "3.3–19.4 mg/L" ],
        [ "Free kappa-to-free lambda light chain ratio, serum", "0.26–1.65" ],
        [ "Free lambda light chain, serum", "5.7–26.3 mg/L" ],
        [ "Gamma globulin, CSF", "6.1–8.3 mg/dL" ],
        [ "Gamma-glutamyltransferase", "" ],
        [ "     (gamma-glutamyl transpeptidase), serum", "Female: 8–40 U/L; male: 9–50 U/L" ],
        [ "Gastrin, serum", "˂100 pg/mL" ],
        [ "Glucose, CSF", "50–75 mg/dL" ],
        [ "Glucose, plasma (fasting)", "70–99 mg/dL" ],
        [ "Glucose-6-phosphate dehydrogenase, blood", "5–15 units/g of hemoglobin" ],
        [ "Glycoprotein α-subunit, serum", "˂1 ng/mL" ],
        [ "Growth hormone, serum", "" ],
        [ "     At rest", "˂5 ng/mL" ],
        [ "     Response to provocative stimuli", ">7  ng/mL" ],
        [ "Haptoglobin, serum", "83–267 mg/dL" ],
        [ "Hematocrit, blood ", "Female: 37%–47%; male: 42%–50%" ],
        [ "Hemoglobin A1C", "4.0%–5.6%" ],
        [ "Hemoglobin, blood", "Female: 12–16 g/dL; male: 14–18 g/dL" ],
        [ "Hemoglobin fractionation", "" ],
        [ "     Hb A", "96%–98%" ],
        [ "     Hb A2", "1.5%–3.5%" ],
        [ "     Hb F", "˂1%" ],
        [ "Hemoglobin, plasma", "˂5.0 mg/dL" ],
        [ "Heparin–anti-factor Xa assay, plasma", "0.3 –0.7 IU/mL [therapeutic range for standard \n(unfractionated) heparin therapy]" ],
        [ "Heparin–platelet factor 4 antibody, serum", "Positive: >0.4 optical density unit" ],
        [ "Hepatic copper", "25–40 μg/g dry weight" ],
        [ "Hepatic iron index", "˂1.0" ],
        [ "Histamine excretion, urine", "20–50 μg/24 hr" ],
        [ "Homocysteine, plasma", "5–15 μmol/L" ],
        [ "β-Human chorionic gonadotropin (β-hCG), serum", "Female, premenopausal nonpregnant: ˂1.0 U/L; female, \npostmenopausal: ˂7.0 U/L; male: ˂1.4 U/L" ],
        [ "β-Human chorionic gonadotropin (β-hCG), urine", "˂2 mIU/24 hr" ],
        [ "Hydroxyproline, urine", "10–30 mg/sq meter of body surface/24 hr" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 48
    },
    {
      "page": 7,
      "tables": [
        [ "Immature platelet fraction", "1%–5% of platelet count" ],
        [ "Immune complexes, serum", "0–50 μg/dL" ],
        [ "Immunoglobulins, serum", "" ],
        [ "     IgA", "90–325 mg/dL" ],
        [ "     IgE", "˂380 IU/mL" ],
        [ "     IgG", "800–1500 mg/dL" ],
        [ "     IgM", "45–150 mg/dL " ],
        [ "Immunoglobulin free light chains, serum", "" ],
        [ "    Kappa", "3.3–19.4 mg/L" ],
        [ "    Lambda", "5.7–26.3 mg/L" ],
        [ " Kappa-to-lambda ratio", "0.26–1.65" ],
        [ "Insulin, serum (fasting)", "˂20 μU/mL" ],
        [ "Insulin-like growth factor 1 (IGF-1)\n     (somatomedin-C), serum", "" ],
        [ "     Ages 16–24", "182–780 ng/mL" ],
        [ "     Ages 25–39", "114–492 ng/mL" ],
        [ "     Ages 40–54", "90–360 ng/mL" ],
        [ "     Ages 55 and older", "71–290 ng/mL" ],
        [ "Iodine, urine", "" ],
        [ "     Random (\"spot\")", "μg/L; varies" ],
        [ "Iron, serum", "50–150 μg/dL" ],
        [ "Iron-binding capacity, serum (total)", "250–310 μg/dL" ],
        [ "Lactate dehydrogenase, serum", "80–225 U/L" ],
        [ "Lactate, arterial blood", "˂1.3  mmol/L (˂1.3 mEq/L)" ],
        [ "Lactate, serum or plasma", "0.7–2.1 mmol/L" ],
        [ "Lactate, venous blood", "0.7–1.8 mEq/L; 6–16 mg/dL" ],
        [ "Lactic acid, serum", "6–19 mg/dL (0.7–2.1 mmol/L)" ],
        [ "Lactose tolerance test, GI", "Increase in plasma glucose: >15 mg/dL" ],
        [ "Lead, blood", "<5.0 μg/dL" ],
        [ "Leukocyte count", "4000–11,000/μL" ],
        [ "     Segmented neutrophils", "50%–70%" ],
        [ "     Band forms", "0%–5%" ],
        [ "     Lymphocytes", "30%–45%" ],
        [ "     Monocytes", "0%–6%" ],
        [ "     Basophils", "0%–1%" ],
        [ "     Eosinophils", "0%–3%" ],
        [ "Lipase, serum", "10–140 U/L " ],
        [ "Lipoprotein(a), serum", "Desirable: ˂30 mg/dL " ],
        [ "Luteinizing hormone (LH), serum", "" ],
        [ " Female, follicular/luteal", "1–12 mIU/mL (1–12 U/L)" ],
        [ "     Female, mid-cycle peak", "9–80 mIU/mL (9–80 U/L)" ],
        [ "     Female, postmenopausal", ">30 mIU/mL (>30 U/L)" ],
        [ "     Male (adult)", "2–9 mIU/mL (2–9 U/L)" ],
        [ "     Children, Tanner stages 1, 2, 3 ", "˂9.0 mIU/mL (˂9.0 U/L)" ],
        [ "     Children, Tanner stages 4, 5", "1–15 mIU/mL (1–15 U/L)" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 44
    },
    {
      "page": 8,
      "tables": [
        [ "Lymphocyte subsets", "" ],
        [ "     CD3", "900–3245/μL" ],
        [ "     CD4", "530–1570/μL" ],
        [ "     CD8", "430–1060/μL" ],
        [ "     CD19\n     CD56", "208–590/μL\n40–500/μL" ],
        [ "Magnesium, serum", "1.6–2.6 mg/dL" ],
        [ "Magnesium, urine", "14–290 mg/24 hr" ],
        [ "Mean corpuscular hemoglobin", "28–32 pg" ],
        [ "Mean corpuscular hemoglobin concentration", "33–36 g/dL" ],
        [ "Mean corpuscular volume", "80–98 fL" ],
        [ "Mean platelet volume", "7–9 fL" ],
        [ "Metanephrines, fractionated, plasma ", "" ],
        [ "   Metanephrine", "˂0.5 nmol/L" ],
        [ "   Normetanephrine", "˂0.9 nmol/L" ],
        [ "Metanephrines, fractionated, 24-hour urine", "" ],
        [ "   Metanephrine", "˂400 μg/24 hr" ],
        [ "   Normetanephrine", "˂900 μg/24 hr" ],
        [ "Methylmalonic acid, serum", "0.00–0.40 μmol/L" ],
        [ "Myoglobin, serum", "˂100 μg/L" ],
        [ "Norepinephrine, plasma", "" ],
        [ "     Supine", "70–750 pg/mL" ],
        [ "     Standing", "200–1700 pg/mL" ],
        [ "Norepinephrine, urine", "0–100 μg/24 hr" ],
        [ "Normetanephrine, fractionated, plasma ", "˂0.9 nmol/L" ],
        [ "Normetanephrine, fractionated, 24-hour urine", "˂900 μg/24 hr" ],
        [ "N-telopeptide, urine", "Female: 11–48 nmol BCE/mmol creatinine; \nmale: 7–68 nmol BCE/mmol creatinine" ],
        [ "N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP), \nserum or plasma", "If eGFR >60 mL/min/1.73 m2\n18–49 years of age\n     Heart failure unlikely:  ≤300 pg/mL\n     High probability of heart failure:  ≥450 pg/mL\n50–75 years of age\n      Heart failure unlikely:  ≤300 pg/mL\n      High probability of heart failure: ≥900 pg/mL\nOlder than 75 years of age\n      Heart failure unlikely:  ≤300 pg/mL\n      High probability of heart failure: ≥1800 pg/mL\nIf eGFR <60 mL/min/1.73 m2\n18 years of age or older\n     High probability of heart failure:  ≥1200 pg/mL" ],
        [ "", "" ],
        [ "", "" ],
        [ "Osmolality, serum", "275–295 mOsm/kg H2O" ],
        [ "Osmolality, urine", "38–1400 mOsm/kg H2O" ],
        [ "Osmotic fragility of erythrocytes", "Increased if hemolysis occurs in over 0.5% NaCl; \ndecreased if hemolysis is incomplete in 0.3% NaCl" ],
        [ "Osteocalcin, serum", "Female: 7.2–27.9 ng/mL; male: 11.3–35.4 ng/mL " ],
        [ "Oxalate, urine", "˂40 mg/24 hr" ],
        [ "Oxygen consumption", "225–275 mL/min" ],
        [ "Oxygen saturation, arterial blood", "≥95%" ],
        [ "Parathyroid hormone, serum", "" ],
        [ "     C-terminal ", "150–350 pg/mL" ],
        [ "     Intact", "10–65 pg/mL" ],
        [ " Intact (dialysis patients only)", "Target: 130–585 pg/mL" ]
      ],
      "merges": {
        "26-0": {
          "row": 26,
          "col": 0,
          "width": 1,
          "height": 3
        },
        "26--1": {
          "row": 26,
          "col": -1,
          "width": 1,
          "height": 3
        },
        "26-1": {
          "row": 26,
          "col": 1,
          "width": 1,
          "height": 3
        }
      },
      "merge_alias": {
        "27-0": "26-0",
        "28-0": "26-0",
        "27--1": "26--1",
        "28--1": "26--1",
        "27-1": "26-1",
        "28-1": "26-1"
      },
      "width": 2,
      "height": 40
    },
    {
      "page": 9,
      "tables": [
        [ "Parathyroid hormone-related protein, serum", "˂1.5 pmol/L" ],
        [ "Partial thromboplastin time (activated)", "25–35 seconds" ],
        [ "pH, urine", "4.5–8.0" ],
        [ "Phenolsulfonphthalein, urine", "At least 25% excreted by 15 minutes; \n40% by 30 minutes; \n60% by 120 minutes" ],
        [ "Phosphatase (acid), serum", "" ],
        [ "     Total", "0.5–2.0 (Bodansky) units/mL" ],
        [ "     Prostatic fraction", "0.1–0.4    unit/mL" ],
        [ "Phosphatase (alkaline), serum", "30–120 U/L" ],
        [ "Phospholipids, serum (total)", "200–300 mg/dL" ],
        [ "Phosphorus, serum", "3.0–4.5 mg/dL" ],
        [ "Phosphorus, urine", "500–1200 mg/24 hr" ],
        [ "Platelet count", "150,000–450,000/μL" ],
        [ "Platelet function analysis (PFA-100):", "" ],
        [ " Collagen–epinephrine closure time", "60–143 seconds" ],
        [ "   Collagen–ADP closure time", "58–123 seconds" ],
        [ "Platelet survival rate (51Cr)", "10 days" ],
        [ "Potassium, serum", "3.5–5.0 mEq/L" ],
        [ "Potassium, urine", "" ],
        [ "     Random (\"spot\")", "mEq/L; varies" ],
        [ "24-hour measurement", "mEq/24 hr; varies with intake" ],
        [ "Prealbumin, serum", "16–30 mg/dL" ],
        [ "Pregnanetriol, urine", "0.2–3.5 mg/24 hr" ],
        [ "Pressure (opening) [initial], CSF", "70–180 mm CSF (70–180 mm H2O); 7–18 cm H2O" ],
        [ "Procalcitonin, serum", "≤0.10 ng/mL" ],
        [ "Progesterone, serum", "" ],
        [ "     Female, follicular", "0.02–0.9 ng/mL" ],
        [ "     Female, luteal", "2–30 ng/mL" ],
        [ "     Male (adult)", "0.12–0.3 ng/mL" ],
        [ "Proinsulin, serum", "3–20 pmol/L" ],
        [ "Prolactin, serum", "˂20 ng/mL" ],
        [ "Prostate-specific antigen, serum", "ng/mL; no specific normal or abnormal level" ],
        [ "Protein C activity, plasma", "65%–150%" ],
        [ "Protein C antigen, plasma", "70%–140%" ],
        [ "Protein catabolic rate, urine ", "goal: 1.0–1.2 g/kg/24 hr" ],
        [ "Protein S activity, plasma", "57%–131%" ],
        [ "Protein S antigen, plasma", "" ],
        [ "  Total", "60%–140%" ],
        [ "  Free", "60%–130%" ],
        [ "Protein, urine", "" ],
        [ "     Random (\"spot\")", "mg/dL; varies" ],
        [ "24-hour measurement", "˂100 mg/24 hr" ],
        [ "Proteins, CSF total", "15–45 mg/dL" ],
        [ "Proteins, serum", "" ],
        [ "      Total", "5.5–9.0 g/dL" ],
        [ "      Albumin", "3.5–5.5 g/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 45
    },
    {
      "page": 10,
      "tables": [
        [ "Proteins, serum (continued)", "" ],
        [ "      Globulin", "2.0–3.5 g/dL" ],
        [ "          Alpha1 ", "0.2–0.4 g/dL" ],
        [ "          Alpha2  ", "0.5–0.9 g/dL" ],
        [ "          Beta", "0.6–1.1 g/dL" ],
        [ "          Gamma", "0.7–1.7 g/dL" ],
        [ "Protein-to-creatinine ratio, urine", "˂0.2 mg/mg" ],
        [ "Prothrombin time, plasma", "11–13 seconds" ],
        [ "Pyruvic acid, blood", "0.08–0.16 mmol/L" ],
        [ "Red cell distribution width (RDW)", "9.0%–14.5%" ],
        [ "Red cell mass", "Female: 22.7–27.9 mL/kg; male: 24.9–32.5 mL/kg" ],
        [ "Renin activity (angiotensin-I radioimmunoassay)", "" ],
        [ "     Peripheral plasma", "" ],
        [ "          Normal diet", "" ],
        [ "               Supine", "0.3–2.5 ng/mL/hr" ],
        [ "               Upright", "0.2–3.6 ng/mL/hr" ],
        [ "          Low sodium diet", "" ],
        [ "               Supine", "0.9–4.5 ng/mL/hr" ],
        [ "               Upright", "4.1–9.1 ng/mL/hr" ],
        [ "          Diuretics + low sodium diet", "6.3–13.7 ng/mL/hr" ],
        [ "     Renal vein concentration", "Normal ratio (high:low): ˂1.5" ],
        [ "Reptilase time", "10–12 seconds" ],
        [ "Reticulocyte count", "0.5%–1.5% of red cells" ],
        [ "Reticulocyte count, absolute", "25,000–100,000/μL" ],
        [ "Rheumatoid factor (nephelometry)", "˂24 IU/mL" ],
        [ "Rheumatoid factor, latex test for", "≤1:80" ],
        [ "Ristocetin cofactor activity of plasma", "See von Willebrand factor activity (ristocetin cofactor \nactivity), plasma" ],
        [ "Russell viper venom time, dilute", "33–44 seconds" ],
        [ "Sex hormone-binding globulin", "Female, nonpregnant: 18–144 nmol/L;\nmale: 10–57 nmol/L" ],
        [ "Sodium, serum", "136–145 mEq/L" ],
        [ "Sodium, urine", "" ],
        [ "   Random (\"spot\")", "mEq/L; varies" ],
        [ "24-hour measurement", "mEq/24 hr; varies with intake" ],
        [ "Specific gravity, urine", "1.002–1.030" ],
        [ "Sperm density", "10–150 million/mL" ],
        [ "Sweat test for sodium and chloride", "˂60 mEq/L" ],
        [ "T3 resin uptake", "25%–35%" ],
        [ "T-lymphocyte count, CD4", "530–1570/μL" ],
        [ "Testosterone, serum", "Female: 18–54 ng/dL; male: 291–1100 ng/dL" ],
        [ "Testosterone, bioavailable, serum", "Female, age 18–69 yrs: 0.5–8.5 ng/dL" ],
        [ "Testosterone, free, serum", "Male: 70–300 pg/mL" ],
        [ "Thrombin time", "17–23 seconds" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 42
    },
    {
      "page": 11,
      "tables": [
        [ "Thyroid function studies", "" ],
        [ "     T3 resin uptake", "25%–35%" ],
        [ "     Thyroglobulin, serum", "˂20 ng/mL" ],
        [ "     Thyroidal iodine (123I) uptake", "5%–30% of administered dose at 24 hours" ],
        [ " Thyroid-stimulating hormone (TSH), serum", "0.5–4.0 μU/mL (0.5–4.0 mU/L)" ],
        [ " Thyroid-stimulating immunoglobulin (TSI)", "˂130%" ],
        [ "     Thyroxine-binding globulin, serum", "12–27 μg/mL" ],
        [ "     Thyroxine index, free (estimate)", "5–12" ],
        [ "     Thyroxine (T4), serum", "" ],
        [ "          Total", "5–12 μg/dL" ],
        [ "          Free", "0.8–1.8 ng/dL" ],
        [ "     Triiodothyronine (T3), serum", "" ],
        [ "          Total", "80–180 ng/dL" ],
        [ "          Reverse", "20–40 ng/dL" ],
        [ "          Free", "2.3–4.2 pg/mL" ],
        [ "Tissue transglutaminase antibody, IgA\n[by chemiluminescence method]", "˂20 AU" ],
        [ "Tissue transglutaminase antibody, IgG\n[by chemiluminescence method]", "˂20 AU" ],
        [ "Tissue transglutaminase antibody, IgA\n[by ELISA]", "˂4.0 U/mL" ],
        [ "Tissue transglutaminase antibody, IgG\n[by ELISA]", "˂6.0 U/mL" ],
        [ "Total proteins, CSF", "15–45 mg/dL" ],
        [ "Transaminase, serum glutamic oxaloacetic (SGOT)", "See Aminotransferase, serum aspartate (AST)" ],
        [ "Transaminase, serum glutamic pyruvic (SGPT)", "See Aminotransferase, serum alanine (ALT)" ],
        [ "Transferrin saturation ", "20%–50%" ],
        [ "Transferrin, serum", "200–400 mg/dL" ],
        [ "Triglycerides, serum (fasting)", "" ],
        [ "     Optimal", "˂100 mg/dL" ],
        [ "     Normal", "˂150 mg/dL" ],
        [ " Borderline-high", "150–199 mg/dL" ],
        [ "     High", "200–499 mg/dL" ],
        [ "     Very high", ">499 mg/dL" ],
        [ "Troponin I, cardiac, serum", "≤0.04 ng/mL" ],
        [ "Troponin T, cardiac, serum", "≤0.01 ng/mL" ],
        [ "Troponin I, cardiac, high-sensitivity, plasma", "Female: ≤15 ng/L; male: ≤20 ng/L" ],
        [ "Troponin T, cardiac, high-sensitivity, plasma", "Female: ≤10 ng/L; male: ≤15 ng/L" ],
        [ "Tryptase, serum", "˂11.5 ng/mL" ],
        [ "Urea clearance, urine", "" ],
        [ "     Standard", "40–60 mL/min" ],
        [ "     Maximal", "60–100 mL/min" ],
        [ "Urea nitrogen, blood", "8–20 mg/dL" ],
        [ "Urea nitrogen, urine", "12–20 g/24 hr" ],
        [ "Uric acid, serum", "3.0–7.0 mg/dL" ],
        [ "Uric acid, urine", "250–750 mg/24 hr" ],
        [ "Uroporphyrin, urine", "10–30 μg/24 hr" ],
        [ "Vanillylmandelic acid, urine", "˂9 mg/24 hr" ],
        [ "Venous oxygen content, mixed", "14–16 mL/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 45
    },
    {
      "page": 12,
      "tables": [
        [ "Venous studies, mixed, blood", "" ],
        [ "     pH", "7.32–7.41" ],
        [ "     PCO2", "42–53 mm Hg" ],
        [ "     PO2", "35–42 mm Hg" ],
        [ "     Bicarbonate", "24–28 mEq/L" ],
        [ "     Oxygen saturation (SvO2)", "65%–75%" ],
        [ "Viscosity, serum", "1.4–1.8 cp" ],
        [ "Vitamin A, serum:", "" ],
        [ "   Adult", "32.5–78.0 μg/dL" ],
        [ "   Pediatric, age 1–2 yr (retinol)", "20–43 μg/dL" ],
        [ "Vitamin B12, serum", "200–800 pg/mL" ],
        [ "Vitamin D metabolites, serum", "" ],
        [ "     1,25-Dihydroxyvitamin D\n          (1,25-dihydroxycholecalciferol)", "15–60 pg/mL" ],
        [ "25-Hydroxyvitamin D\n(25-hydroxycholecalciferol)", "30–60 ng/mL" ],
        [ "Vitamin E, serum:", "" ],
        [ "   Adult", "5.5–17.0 mg/L" ],
        [ " Pediatric, age 1–2 yr (alpha-tocopherol)", "2.9–16.6 mg/L" ],
        [ "Volume, blood", "" ],
        [ "     Plasma", "Female: 43 mL/kg body weight; \nmale: 44 mL/kg body weight" ],
        [ "     Red cell", "Female: 20–30 mL/kg body weight;\nmale: 25–35 mL/kg body weight " ],
        [ "von Willebrand factor activity (ristocetin cofactor\nactivity), plasma", "50%–150%" ],
        [ "von Willebrand factor antigen, plasma", "50%–150%" ],
        [ "Zinc, serum", "75–140 μg/dL" ]
      ],
      "merges": {},
      "merge_alias": {},
      "width": 2,
      "height": 23
    }
  ],
  "numPages": 12,
  "currentPages": 12
}